REmote CArdiac MOnitoring by the Corsano CardioWatch 287-2 Evaluation Study

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

December 28, 2023

Study Completion Date

December 28, 2023

Conditions
Atrial FibrillationRhythm; DisorderPalpitationsHypertensionHypotension
Interventions
DEVICE

Corsano CardioWatch 287-2

Patients receive either an EKG holter or an automatic blood pressure cuff, as prescribed by their cardiologist. The readings from these devices (atrial fibrillation detection and blood pressure) will be compared to the readings from the CardioWatch 287-2.

Trial Locations (1)

2625 AD

Reinier de Graaf Gasthuis, Delft

Sponsors
All Listed Sponsors
lead

Corsano Health B.V.

INDUSTRY

NCT05899959 - REmote CArdiac MOnitoring by the Corsano CardioWatch 287-2 Evaluation Study | Biotech Hunter | Biotech Hunter